A comprehensive technique was developed for using threedimensional 17 O magnetic resonance spectroscopic imaging at 9.4T for rapidly imaging the cerebral metabolic rate of oxygen consumption (CMRO2) in the rat brain during a two-min inhalation of 17 O2. The CMRO2 value (2.19 ؎ 0.14 mol͞g͞min, n ‫؍‬ 7) was determined in the rat anesthetized with ␣-chloralose by independent and concurrent 17 O NMR measurements of cerebral H2 17 O content, arterial input function, and cerebral perfusion. CMRO2 values obtained were consistent with the literature results for similar conditions. Our results reveal that, because of its superior sensitivity at ultra-high fields, the 17 O magnetic resonance spectroscopic imaging approach is capable of detecting small dynamic changes of metabolic H2 17 O during a short inhalation of 17 O2 gas, and ultimately, for imaging CMRO2 in the small rat brain. This study provides a crucial step toward the goal of developing a robust and noninvasive 17 O NMR approach for imaging CMRO2 in animal and human brains that can be used for studying the central role of oxidative metabolism in brain function under normal and diseased conditions, as well as for understanding the mechanisms underlying functional MRI.
O NMR approach for fast imaging of cerebral metabolic rate of oxygen in rat brain at high field,'' by Xiao-Hong Zhu, Yi Zhang, Run-Xia Tian, Hao Lei, Nanyin Zhang, Xiaoliang Zhang, Hellmut Merkle, Kamil Ugurbil, and Wei Chen, which appeared in number 20 This correction should not significantly affect the major conclusions and methodology presented in this article. However, the correction could reveal that the current sensitivity of 17 O NMR and, alternatively, the spatial resolution of the 17 O MRS image achieved at 9.4 tesla may be potentially limited for determining and imaging CMRO 2 in small brain structures such as the white matter in the rat brain.
I
n the brain, the majority of energy consumption occurs by neuronal activity (1) . This energy need is met predominantly through oxygen consumption mediated by the mitochondrial respiratory chain, coupled to oxidation of glucose as the main carbon source (2) . The oxidative energy need of the human brain to sustain neuronal activity constitutes a large fraction of the energy requirements (Ϸ20%) in the entire body. The central role played by oxygen consumption is also evident in pathologies associated with the brain; perturbations in brain oxidative metabolism have been closely linked to many brain diseases such as schizophrenia, Alzheimer's disease, Huntington's disease, Parkinson's disease, and mitochondrial dysfunction, as well as aging problems (3) (4) (5) (6) (7) . One line of evidence linking these diseases and cerebral oxidative metabolism is the histopathological finding that the activity of cytochrome oxidase, the key mitochondrial enzyme that catalyzes the reduction of oxygen to form water, is impaired in patients with schizophrenia (3) and Alzheimer's disease (4, 5) .
Basal cerebral oxygen consumption is not uniform across different regions in the brain. It is recognized that capillary density in the brain is inhomogeneous (ref. 8 and refs. therein) , suggesting that mitochondrial density, and hence, oxygen consumption are also likely to be inhomogeneous because a good correlation exists between capillarity and mitochondrial density in tissues (9) . Alterations in neuronal activity due to stimulation or performance of a task increases this spatial nonuniformity by inducing regional changes in oxygen utilization as well as in blood flow and glucose consumption (10) (11) (12) . In addition, the impairment in cytochrome oxidase content in the diseased brain was also found to affect different regions in the brain selectively (3) (4) (5) . These considerations imply that the ability to image the cerebral metabolic rate of oxygen consumption (CMRO 2 ) in vivo is essential for efforts aimed at investigating cerebral oxidative metabolism under normal and pathological conditions.
The earliest approach of CMRO 2 measurement is based on the Kety-Schmidt method for measuring cerebral blood flow (CBF) together with arteriovenous differences of oxygen content (13) . This method, thought to be the most accurate one in the literature, provides only global CMRO 2 information without spatial differentiation within the brain. Positron emission tomography (PET) has been widely used for imaging CMRO 2 in humans (14) (15) (16) . By introducing oxygen gas enriched with the isotope 15 The 13 C NMR methods based on monitoring the cerebral metabolism of intravenously infused [1-13 C] glucose (e.g., (10, 11, 17, 18) ) provide an alternative approach for CMRO 2 measurements. The labeling kinetics for several intracellular metabolites, most importantly glutamate, can be unequivocally measured by these methods; extraction of CMRO 2 from experimental data relies on extensive modeling (10, 11, 18, 19) . In addition, the 13 C NMR methods require a long measurement time (60-120 min) because of relatively slow turnover rates of cerebral metabolites, and it is difficult, although not impossible, to achieve three-dimensional (3D) CMRO 2 imaging because of a relatively long repetition time required for signal acquisitions.
The possibility of using the 17 O NMR spectroscopy͞imaging techniques for monitoring labeled H 2 17 O as a tracer of oxygen utilization or tissue perfusion have been introduced a decade ago (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . These early studies can be divided into two distinct groups. The first group involved the simple 17 O NMR approach for detecting H 2 17 O directly (20, 21, (24) (25) (26) (27) . Nonlocalized 17 O NMR was used for most studies to estimate CMRO 2 in the whole brain of experimental animals as well as in the human occipital lobe (31) after inhalation of oxygen gas enriched with the 17 O isotope ( 17 O 2 ). Few studies attempted to obtain a coarse CMRO 2 image (Ն800 l voxel size) in the cat brain with a long measurement time (25, 27) . These previous efforts, all of which were conducted at relatively low fields compared with what is available currently, demonstrated the dramatic limitations imposed by the low inherent sensitivity of 17 O NMR due to its low Abbreviations: CMRO2, cerebral metabolic rate of oxygen; CBF, cerebral blood flow; PET, positron emission tomography; 3D, three-dimensional; MRS, magnetic resonance spectroscopic; SNR, signal-to-noise ratio. 
where C a (t), C b (t), and C 2 17 O ϭ 19.0. Therefore, we prefer to use convenient units of mol͞(g of brain water) for C b (t) and mol͞(g of blood water) for C a (t) and C v (t). CMRO 2 is expressed in the conventional unit of mol͞min͞(g brain tissue) and is converted from the unit of mol͞min͞(g brain water) by using the conversion constant f 1 given by f 1 ϭ (g of brain tissue)͞(g of brain water) ϭ 1͞␤ brain ϭ 1.266, where ␤ brain is 0.79 (14, 27) . The constant f 2 is also a unit conversion factor and is given by f 2 ϭ blood⅐ ␤ blood ͞␤ brain ϭ 1.05 ϫ 0.81͞0.79 ϭ 1.077, where blood ϭ (g blood)͞(ml blood) ϭ 1.05 (33) , and ␤ blood ϭ (g blood water)͞(g blood) ϭ 0.81 (14) . If water in brain tissue is in equilibrium with water in venous blood (i.e., fast water exchange across capillaries), f 2 C v (t) ϭ C b (t)͞ where ϭ 0.90 is the brain͞blood partition coefficient with the unit of (ml blood)͞(g of brain tissue) (34) . Substituting this relation and introducing two new correction parameters (n and m) into Eq. 1 leads to
[2]
The solution of Eq. 2 is
where m is a correction factor accounting for the limited permeability of water because water is not freely diffusible across the brain-blood barrier; the value of m is 0.84 for the CBF range that we studied herein (35) . The constant n is another correction factor that accounts for the additional restriction on the permeability of the H O through the internal carotid artery gives the value of n. Limited permeability for the metabolic water has been reported in the human brain (36) .
The CMRO 2 value can be precisely calculated by using Eq. 3 if all parameters of C b (t), CBF, and C a (t) can be experimentally measured for the same animal brain. The C b (t) and CBF values can be determined by using C a (t), we designed an implanted 17 O rf coil that permits the continuous measurement of C a (t) in a rat carotid artery. This measurement can be simultaneously performed with C b (t) measurement during an inhalation of 17 O 2 by using separate rf channels on the MR spectrometer equipped with multiple receivers. In principle, the C a (t) function is determined by the metabolic H 2 17 O generated in the entire animal body and the equilibration of this H 2 17 O with the blood compartment. Considering that the oxygen consumption rate is constant (i.e., time independent) in all tissues during the short inhalation time, one can approximate C a (t) as a linear function of time [i.e., C a (t) ϭ At, where A is a constant]. This approximation was supported by our experimental results (see Fig. 5 presented later) and the literature. Then, the solution of Eq. 3 for CMRO 2 is
Therefore, according to Eq. 4, the CMRO 2 value can be calculated by experimental data on CBF, A, n, C b (t), and other known constants (f 1 , f 2 , m, ␣, and ) for each data point measured at different inhalation times for each voxel. All CMRO 2 values reported (except for those in CBF values can be determined from the ''washout'' rate of the tracer H 2 17 O in the brain tissue following a rapid bolus injection of H 2 17 O through one carotid artery (32) according to Eq. 5:
where C b (0) is the cerebral H 2 17 O concentration after the arrival of all labeled water after the bolus injection. Fitting the exponential decay of the H 2 17 O washout curve according to Eq. 5 gives the CBF value. (32, 37) . In this method, the k-space sampling is weighted according to the Fourier coefficients of a predetermined voxel shape to achieve an optimal filter applied at the acquisition stage. A cylindrical voxel shape (circular shape on the coronal orientation) was used in this study (37) . Short T 1 value (4.5 ms) of cerebral H 2 17 O in the rat allows rapid signal acquisition, and ultimately, more signal averages within the same sampling time (32) . Therefore, a short TR of 12 ms (Ϸ3T 1 ) was used for gaining SNR. The acquisition time for each 3D 17 O-MRS image was 11 s (total scan number ϭ 948; rf pulse width ϭ 50 s, spectral width ϭ 30 kHz; FOV ϭ 18 ϫ 18 ϫ 15 mm 3 , 9 ϫ 9 ϫ 5 phase encodes). Phase-encoding gradient was 0.35 ms long and had a half-sine waveform, which allowed for a short gradient echo time (TE ϭ CBF Measurements. For CBF measurements, one external carotid artery was catheterized with a PE-50 tubing for gaining access to the internal carotid artery without interrupting blood circulation into the brain (32) . A 0.05-0.1 ml 50%-enriched H 2 17 O was rapidly injected into the brain through the internal carotid artery for CBF measurements using 17 
Materials and Methods
0.4 ms). This short TE is critical for minimizing signal loss because of the relatively fast transverse relaxation of the 17 O magnetization (T 2 ϭ 3.0 ms at 9.4T; ref. 32). The peak strength of the phase-encoding gradient increment was 0.09-0.11 G͞cm. The image voxel size was 27 l. A 17 ϫ 17 ϫ 9 matrix of free induction decay (FIDs) were generated from the original 9 ϫ 9 ϫ 5 phase encode data for each 3D 17 O image. The FIDs were zero-filled, and a 100-Hz line broadening (LB) was used before fast Fourier transformation for SNR enhancement.
O MRS imaging (32).

Ca(t)
Measurements. An implanted vascular rf coil was designed and constructed for continuously detecting the 17 O NMR signal changes of H 2 17 O in the rat carotid artery at 9.4T. This coil was based on a modified solenoid coil design combined with an rf shielding. § The rf shielding ensured that the NMR signal detected by the implanted coil was only attributed by the artery blood (Ϸ7 l) without contaminations from surrounding tissues. Therefore, additional spatial localization was not necessary for determining C a (t). In addition, the rf shielding minimized the electromagnetic coupling between the implanted 17 O coil and the head 17 O surface coil tuned at the same operating frequency (two-coil arrangement), which allowed simultaneous measurements of both C a (t) and C b (t) by using two receiver channels with the same temporal resolution (11 s). Olabeled O 2 gas with 58.2-72.1% enrichment (Isotec) was mixed with N 2 O gas (Ϸ2:3) and then stored in a cylindrical gas reservoir. The 3D 17 O MRS imaging acquisitions were started with the normal gas mixture first for 2 min; these natural abundance 3D 17 O MRS images were used as references for quantifications of metabolic H 2 17 O concentrations in the rat brain during and after the 17 O 2 inhalation. Subsequently, the respiration gas was quickly switched to the 17 O 2 -labeled gas mixture. After 2 min of 17 O 2 inhalation, the gas line was switched back to the normal gas mixture, and the 3D 17 O MRS imaging acquisitions were continued throughout the procedure; a total of 100 images were collected in about 19 min.
Determination of Constant n.
The ratio between the washout rate of the metabolic H 2 17 O after the cessation of 17 O 2 inhalation and the washout rate of the H 2 17 O trace from the H 2 17 O bolus injected through the rat internal carotid artery gave the value of constant n for each voxel.
All results are presented as mean Ϯ SD.
Results
The multinuclear surface-coil probe was used to collect a series of global 17 H nuclei, the repetition time (TR) was Ϸ3T 1 in both cases; the total acquisition time was 6.2 s for all spectra. Under this condition, we found that the signal fluctuations in the consecutively acquired spectra for the two nuclei were comparable (SD ϭ 0.20% for 1 H spectra; SD ϭ 0.35% for 17 O spectra). This result demonstrates that with respect to the capability for detecting fractional changes in NMR signal intensity, the Fig. 3 O MRS imaging. The washout curves excluding the first data point were fitted to an exponential decay function according to Eq. 5, and these fits yielded CBF values. Fig. 4 demonstrates one example of CBF measurement obtained from the same rat and image voxel used in Fig. 3 showing the stacked plot of 17 O spectra and the exponential fit. Because the H 2 17 O bolus was injected into one of the internal carotid arteries, and the H 2 17 O tracer was mainly distributed into the ipsilateral hemisphere, CBF and, subsequently, CMRO 2 quantifications were performed only for the 17 O image voxels in the ipsilateral hemisphere of the rat brain. Fig. 5A illustrates the natural abundance H 2 17 O spectrum from the blood in the rat carotid artery. Fig. 5B plots the results of simultaneous measurements of C a (t) change in one carotid artery and C b (t) change in a voxel in the ipsilateral hemisphere 1 H NMR spectra of natural abundance water in the rat brain acquired and processed with the following parameters: NT ϭ 1, TR ϭ 6.2s, LB ϭ 25Hz (Ϸ half linewidth). The SD of the 1 H water peak height in these spectra is 0.20%. (B) Stacked plot of 25 17 O NMR spectra of natural abundance water in the rat brain acquired and processed with the following parameters: NT ϭ 512, TR ϭ 12ms for each scan, LB ϭ 100Hz (Ϸ half linewidth); the SD of the 17 O water peak height in these spectra is 0.35%. The total acquisition times for each 1 H and 17 O spectra were the same (6.2 s).
brain during an inhalation of 17 O 2 . The C a (t) data were fitted by a linear function for calculating the value of constant A. Finally, the values of C b (t), CBF, and n from each voxel and the value of A measured from each 17 O inhalation measurement were used to calculate CMRO 2 according to Eq. 4. Fig. 5C demonstrates one example of CMRO 2 calculations as a function of time from a single voxel. It is evident in Fig. 5C that the CMRO 2 value is independent of the inhalation time if the initial two points are excluded. The averaged CMRO 2 values (excluding two initial points) and CBF values from seven measurements are 2.19 Ϯ 0.14 mol͞g͞min and 0.53 Ϯ 0.07 ml͞g͞min, respectively, in the rat brains anesthetized with ␣-chloralose.
The mean CBF and n values obtained from the entire hemisphere ipsilateral to the internal carotid artery where a H 2 17 O bolus was injected were subsequently used to calculate CMRO 2 values for both ipsilateral and contralateral hemispheres approximately and to obtain 3D CMRO 2 images. This approximation was made based on the fact that the CBF distribution in the hemisphere where it was measured was relatively uniform and that two hemispheres should be equivalent with respect to CBF. Fig. 6 illustrates three adjacent CMRO 2 images in the coronal orientation from a representative rat brain. The inhomogeneous signal intensity caused by the surface coil sensitivity profile (Fig.  2) is not reflected in the CMRO 2 maps, as expected.
Discussion
The 17 O T 1 value in H 2 17 O is less than 5 ms in the rat brain at 9.4T (32) . This short T 1 permits much faster data acquisitions, more signal averages, and, consequently, a high SNR per unit of time. This advantage is critical for the success of CMRO 2 measurement using direct (29) , which is difficult to detect reliably because this change is comparable to the signal fluctuations in consecutively acquired 1 H spectra or images. These signal fluctuations are not dominated by the inherent SNR of a single spectrum or image but are mainly determined by the physiological processes of breathing, heart pulsation, and vasomotion, as well as NMR scanner instability. In contrast, 17 2 17 O concentration reaches a new steady state within a short time (6-10 min); this fast recovery should allow repeated CMRO 2 measurements in the same subject and same experimental session. This capability is essential for studying the oxidative metabolism changes related to perturbations in physiology and function, where at least two measurements are required under control and perturbation conditions. Finally, at ultra-high fields the 17 O NMR sensitivity is adequate to obtain relatively high-resolution images, even relative to the small size of the rat brain, with an 11-s acquisition time; this sensitivity makes the 17 O approach possible for imaging CMRO 2 within a short measurement duration (2 min).
Because of the technical challenges faced for most existing CMRO 2 imaging methods, there is virtually no literature reporting direct measurements of CMRO 2 in the rat brain. For instance, the image voxel size of most conventional PET scanners is on the order of several milliliters (e.g., ref. 38); this size is already larger than the size of the entire rat brain. Nevertheless, we compared our result of CMRO 2 measurement by using (39) , cerebral metabolic rate of glucose (CMR glc ) was recently determined to be Ϸ0.37 mol͞g͞min in the somatosensory and motor cortices of rats anesthetized with ␣-chloralose. By using the CMRO 2 ͞CMR glc ratio of 5.5 (2), a CMRO 2 value of 2.04 mol͞g͞min is calculated from this CMR glc measurement, which is in excellent agreement with our 17 O-based CMRO 2 result (2.19 Ϯ 0.14 mol͞g͞min). The CBF value of 0.58-0.68 ml͞g͞min reported in the same autoradiographic study (39) is also close to the mean CBF value of 0.53 Ϯ 0.07 ml͞g͞min measured in our study. The heteronuclear editing MRS and 1 H MRI methods covering a large range of cortical activity at different anesthesia conditions had been used to measure CMRO 2 and CBF values in the sensory motor cortex of mature rats, and a linear correlation between CMRO 2 and CBF was observed (CMRO 2 ϭ 3.76⅐CBF ϩ 0.18, R 2 ϭ 0.99; ref. 40 ). The estimated CMRO 2 from this relation is 2.16 mol͞g͞min if the CBF value observed in our study (0.53 ml͞g͞min) is applied. This CMRO 2 value is again in excellent agreement with our result. These comparisons provide mutual support between our direct CMRO 2 measurements and other indirect measurements reported in the literature and support the validity of the 3D CMRO 2 imaging using 17 O NMR. The CMRO 2 measurements presented in this paper involved two invasive procedures: one for determining C a (t) by means of the implanted 17 O rf coil, and the second for measuring CBF by an intra-arterial catheter and bolus injection of H 2 17 O. The CBF measurement can be performed noninvasively by using the arterial spin tagging MR approaches (41) . The implanted rf coil, on the other hand, is not practical for routine measurements of CMRO 2 by using small experimental animal models (e.g., rat or mouse), nor is it suitable for human applications. Therefore, it would be important to explore further the feasibility of the 17 O NMR approach for reliably imaging CMRO 2 without resorting to invasive C a (t) measurements. A successful outcome from such a study will establish a completely noninvasive 17 O approach for CMRO 2 imaging.
In comparison with most existing approaches, the high-field 17 O NMR method requires a significantly short measurement time for imaging CMRO 2 and can be performed within a 2-min 17 O 2 inhalation period. However, this method assumes that CMRO 2 is constant during the measurement. SNR considerations suggest that the CMRO 2 measurement time can further shorten at 9.4T or higher magnetic fields. Although rapid dynamic changes of CMRO 2 that occur faster than this time-scale will be beyond the reach of this method, this time-scale is faster than any other technique currently available for assessing CMRO 2 , especially at the spatial resolution available from the 17 O NMR approach.
Conclusion
We have successfully developed a comprehensive technique by using 17 O MRS imaging at ultra-high field for fast imaging of CMRO 2 in the rat brain and validated it with complementary measurements. The overall results from our study provide an essential step toward the goal for developing a robust, fast, reliable, and noninvasive 17 O NMR approach for imaging the rate of oxidative metabolism for both animal and human brains and, potentially, for other living organs. Such an approach would be useful for studying the central role of oxidative metabolism in brain function under normal and diseased conditions, as well as for understanding the mechanisms underlying functional MRI (42) .
